Literature DB >> 25861861

Perspective on computational and structural aspects of kinase discovery from IPK2014.

Eric Martin1, Stefan Knapp2, Richard A Engh3, Henrik Moebitz4, Thibault Varin5, Benoit Roux6, Jens Meiler7, Valerio Berdini8, Alexander Baumann9, Michal Vieth10.   

Abstract

Recent advances in understanding the activity and selectivity of kinase inhibitors and their relationships to protein structure are presented. Conformational selection in kinases is studied from empirical, data-driven and simulation approaches. Ligand binding and its affinity are, in many cases, determined by the predetermined active and inactive conformation of kinases. Binding affinity and selectivity predictions highlight the current state of the art and advances in computational chemistry as it applies to kinase inhibitor discovery. Kinome wide inhibitor profiling and cell panel profiling lead to a better understanding of selectivity and allow for target validation and patient tailoring hypotheses. This article is part of a Special Issue entitled: Inhibitors of Protein Kinases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer cell panel profiling; Conformational selection; DFG in–out transition; Kinase inhibition profile; Kinase inhibitor

Mesh:

Substances:

Year:  2015        PMID: 25861861      PMCID: PMC5105597          DOI: 10.1016/j.bbapap.2015.03.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Comprehensive analysis of kinase inhibitor selectivity.

Authors:  Mindy I Davis; Jeremy P Hunt; Sanna Herrgard; Pietro Ciceri; Lisa M Wodicka; Gabriel Pallares; Michael Hocker; Daniel K Treiber; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2011-10-30       Impact factor: 54.908

2.  Chemical target and pathway toxicity mechanisms defined in primary human cell systems.

Authors:  Ellen L Berg; Jian Yang; Jennifer Melrose; Dat Nguyen; Sylvie Privat; Elen Rosler; Eric J Kunkel; Sean Ekins
Journal:  J Pharmacol Toxicol Methods       Date:  2009-10-29       Impact factor: 1.950

Review 3.  Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery tool.

Authors:  Espen Åberg; Bjarte Lund; Alexander Pflug; Osman A B S M Gani; Ulli Rothweiler; Taianà M de Oliveira; Richard A Engh
Journal:  Biol Chem       Date:  2012-10       Impact factor: 3.915

4.  Rosetta Ligand docking with flexible XML protocols.

Authors:  Gordon Lemmon; Jens Meiler
Journal:  Methods Mol Biol       Date:  2012

Review 5.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

6.  VX680 binding in Aurora A: π-π interactions involving the conserved aromatic amino acid of the flexible glycine-rich loop.

Authors:  Taianá M Oliveira; Rafi Ahmad; Richard A Engh
Journal:  J Phys Chem A       Date:  2011-02-09       Impact factor: 2.781

7.  Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.

Authors:  Mariusz Butkiewicz; Edward W Lowe; Ralf Mueller; Jeffrey L Mendenhall; Pedro L Teixeira; C David Weaver; Jens Meiler
Journal:  Molecules       Date:  2013-01-08       Impact factor: 4.411

8.  Evaluating the predictivity of virtual screening for ABL kinase inhibitors to hinder drug resistance.

Authors:  Osman A B S M Gani; Dilip Narayanan; Richard A Engh
Journal:  Chem Biol Drug Des       Date:  2013-10-01       Impact factor: 2.817

9.  Spatiotemporal and functional characterisation of the Plasmodium falciparum cGMP-dependent protein kinase.

Authors:  Christine S Hopp; Christian Flueck; Lev Solyakov; Andrew Tobin; David A Baker
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.

Authors:  Pietro Ciceri; Susanne Müller; Alison O'Mahony; Oleg Fedorov; Panagis Filippakopoulos; Jeremy P Hunt; Elisabeth A Lasater; Gabriel Pallares; Sarah Picaud; Christopher Wells; Sarah Martin; Lisa M Wodicka; Neil P Shah; Daniel K Treiber; Stefan Knapp
Journal:  Nat Chem Biol       Date:  2014-03-02       Impact factor: 15.040

View more
  2 in total

1.  Substrate binding to Src: A new perspective on tyrosine kinase substrate recognition from NMR and molecular dynamics.

Authors:  Mehul K Joshi; Robert A Burton; Heng Wu; Andrew M Lipchik; Barbara P Craddock; Huaping Mo; Laurie L Parker; W Todd Miller; Carol Beth Post
Journal:  Protein Sci       Date:  2019-11-21       Impact factor: 6.725

2.  Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia.

Authors:  Kristina Kesely; Panae Noomuna; Michal Vieth; Philip Hipskind; Kasturi Haldar; Antonella Pantaleo; Francesco Turrini; Philip S Low
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.